Congress just discovered you can gamble on whether FDA will approve your meds

Two senators have sent a letter raising alarm over prediction markets where people can bet on the outcomes of clinical drug trials and FDA regulatory approvals. The platforms Kalshi and Polymarket allow users to speculate on whether specific drugs will pass their trials or get government clearance, turning scientific progress into a speculative financial instrument.

For the average person, this means the fate of potentially life-saving medications is now intertwined with gambling markets. Senators argue this creates perverse incentives, could influence patient decisions about joining trials, and opens the door to insider trading by researchers. The takeaway: the financialization of everything has now reached the point where you can place bets on whether your prescription gets approved.